We hypothesized that a MALDI mass spectrometric signature associated with response to IL-2 in melanoma could stratify outcomes in RCC and that the adverse role of HGF [2], an apoptotic marker [3] promoting autophagy [4] could be confirmed. This evidence concerns the gene IL2 and melanoma.